Effect of GM-CSF on HIV-1 replication in monocytes/macrophages in vivo and in vitro: A review

Veterinary Immunology and Immunopathology

Volumn 63, Issue 1-2, 1998, Pages 111-121

  Kedzierska, K ^a   Rainbird, M A ^a   Lopez, A F ^a   Crowe, S M ^a  

^a NONE

Author keywords

GM CSF; HIV; Macrophage

Indexed keywords

ANTIGEN P24; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR RECEPTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VIRUS RNA;

CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE; MONOCYTE; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0032524148     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-2427(98)00087-7     Document Type: Article

References (52)

1. Antman, K.S., Griffin, J.D., Elias, A., 1988. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on chemotherapy-induced myelosuppression. New Engl. J. Med. 319, 593-598.
2. Barre-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vezinet-Brun, F., Rouzioux, C., Rozenbaum, W., Montagnier, L., 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 22, 868-871.
3. Bermudez, L.E., 1994. Potential role of cytokines in disseminated mycobacterial infections. Eur. J. Clin. Microbiol. Infect. Dis. Suppl. 2, S29-S33.
4. Brandt, S.J., Peters, W.P., Buckner, C.D., 1988. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high dose chemotherapy and autologous bone marrow transplantation. New Engl. J. Med. 318, 869-876.
5. Bratton, D.L., Hamid, Q., Boguniewich, M., Doherty, D.E., Kailey, J.M., Leung, D.Y., 1995. Granulocyte-macrophage colony-stimulating factor contributes to enhanced monocyte survival in chronic atopic dermatitis. J. Clin. Invest. 95, 211-218.
6. Brown, C.B., Hart, C.E., Curtis, D.M., Bailey, M.C., Kaushansky, K., 1990. The neutralizing monoclonal antibodies against human granulocyte-macrophage colony-stimulating factor recognize binding domain of the molecule. J. Immunol. 144, 2184-2189.
7. Clark-Lewis, I., Lopez, A.F., To, L.B., Vadas, M.A., Schrader, J.W., Hood, L.E., Kent, S.B.H., 1988. Structure-function studies of human granulocyte-macrophage colony-stimulating factor. Identification of residues required for activity. J. Immunol. 141, 881-889.
8. Crowe, S.M., Mills, J., McGrath, M.S., 1987. Quantitative immunocytofluorographic analysis of CD4 surface antigen expression and HIV infection of human peripheral blood monocytes/macrophages. AIDS Res. Hum. Retroviruses 3, 135-145.
9. Denis, M., Ghadirian, E., 1994. Interleukin 13 and interleukin 4 protect bronchoalveolar macrophages from productive infection with human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses 10, 795-802.
10. Diederichs, K., Boone, T., Karplus, P.A., 1991. Novel fold and putative receptor binding site of granulocyte-macrophage colony-stimulating factor. Science 254, 1779-1782.
11. Eischen, A., Vincent, F., Bergerat, J.P., Louis, B., Faradji, A., Bohbot, A., Oberling, F., 1991. Long term cultures of human monocytes in vitro, impact of GM-CSF on survival and differentiation. J. Immunol. Meth. 143, 209-221.
12. Elliott, M.J., Vadas, M.A., Eglinton, J.M., Park, L.S., To, L.B., Cleland, L.G., Clark, S.C., Lopez, A.F., 1989. Recombinant human interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) show common biological effects and binding char-acteristics on human monocytes. Blood 74, 2349-2359.
13. Folks, T.M., Justement, J., Kinter, A., Dinarello, C.A., Fauci, A.S., 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238, 800-802.
14. Gallo, R.C., Salahuddin, S.Z., Popovic, M., Shearer, G.M., Kaplan, M., Haynes, B.F., Palker, T.J., Redfield, R., Oleske, J., Safai, B., White, F., Foster, R., Markham, P.D., 1984. Frequent detection and isolation of cytopathic retroviruses detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science 224, 500-503.
15. Gartner, S., Markovits, P., Markovitz, D.M., Kaplan, M.H., Gallo, R.C., Popovic, P., 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 223, 215-219.
16. Gearing, D.P., King, J.A., Gough, N.M., Nicola, N.A., 1989. Expression cloning of a receptor for human granulocyte-macrophage colony stimulating factor. EMBO J. 8, 3667-3676.
17. Groopman, J.E., Mitsuyasu, R.T., DeLeo, M.J., Oette, D.H., Golde, D.W., 1987. Effect of recombinant granulocyte-macrophage colony-stimulating factor on myelopoiesis in the Acquired Immunodeficiency Syndrome. New Engl. J. Med. 317, 593-598.
18. Hammer, S.M., Gillis, J.M., Pinkston, P., Rose, R.M., 1990. Effect of zidovudine and granulocyte-macrophage colony-stimulating factor on human immunodeficiency virus replication in alveolar macrophages. Blood 75, 1215-1219.
19. Hayashida, K., Kitamura, T., Gorman, D.M., Arai, K., Yokota, T., Miyajima, A., 1990. Molecular cloning of a second subunit of the receptor for human granulocyte-macrophage colony stimulating factor (GM-CSF): reconstitution of a high affinity GM-CSF receptor. Proc. Natl. Acad. Sci. USA. 87, 9655-9659.
20. Hercus, T.R., Cambareri, B., Dottore, M., Woodcock, J., Bagley, C.J., Vadas, M.A., Shannon, M.F., Lopez, A.F., 1994a. Identification of residues in the first and fourth helices of human granulocyte-macrophage colony-stimulating factor involved in biologic activity and in binding to the alpha- and beta-chains of its receptor. Blood 83, 3500-3508.
21. Hercus, T.R., Bagley, C.J., Cambareri, B., Dottore, M., Woodcock, J.M., Vadas, M.A., Shannon, F., Lopez, A.F., 1994. Specific human granulocyte-macrophage colony-stimulating factor antagonists. Proc. Natl. Acad. Sci. U.S.A., Vol. 91, 5828-5842.
22. Iversen, P.O., Lo, L.B., Lopez, A.F., 1996. Apoptosis of hemopoietic cells by the human granulocyte macrophage colony-stimulating factor mutant E21R. Proc. Natl. Acad. Sci. USA. 93, 2785-2789.
23. Kaplan, L.D., Kahn, J.O., Crowe, S., Northfelt, D., Neville, P., Grossberg, H., Abrams, D.I., Tracey, J., Mills, J., Volberding, P.A., 1991. Clinical and virological effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of randomized trial. J. Clin. Oncol. 9, 929-940.
24. Kornbluth, R.S., Oh, P.S., Munis, J.R., Cleveland, P.H., Richman, D.D., 1989. Interferons and bacterial lipopolysaccharide protect macrophages from productive infection. J. Exp. Med. 169, 1137-1151.
25. Koyanagi, Y., O'Brien, W.A., Zjao, J.Q., Golde, D.W., Gasson, J.C., Chen, I.S.Y., 1988. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. Science 241, 1673-1675.
26. Krown, S.E., Pardes, J., Bundow, D., Polsky, B., Gold, J.W.M., Homenberg, N., 1992. Interferon-alpha, zidovudine and granulocyte macrophage colony stimulating factor: a phase I AIDS clinical trials group study in patients with Kaposi's Sarcoma associated with AIDS. J. Clin. Oncol. 10, 1344-1351.
27. Lafeuillade, A., Poggi, C., Tamalet, C., 1996. GM-CSF increases HIV-1 load. Lancet 347, 1123-1124.
28. Laursen, A.L., Moller, B., Rungby, J., Petersen, C.M., Andersen, P.L., 1994. Pneumocystis carinii-induced activation of the respiratory burst in human monocytes and macrophages. Clin. Exp. Immunol. 98, 196-198.
29. Lopez, A.F., Shannon, M.F., Hercus, T., Nicola, N.A., Cambareri, B., Dottore, M., Layton, M.J., Ellinton, L., Vadas, M.A., 1992. Residue 21 of human granulocyte-macrophage colony-stimulating factor is critical for biological activity and for high but not low affinity binding. EMBO J. 11, 909-916.
30. Matsuda, S., Akagawa, K., Honda, M., Yokota, Y., Takebe, Y., Takemori, T., 1995. Suppression of HIV replication in human monocyte-derived macrophages induced by granulocyte/macrophage colony-stimulating factor. AIDS Res. Hum. Retroviruses 11, 1031-1038.
31. McUrath, M.J., Pruett, J.E., Cohn, Z.A., 1989. Mononuclear phagocytes of blood and bone marrow: comparative roles as viral reservoirs in human immunodeficiency virus type 1 infections. Proc. Natl. Acad. Sci. USA. 86, 675-679.
32. Metcalf, D., 1985. The granulocyte-macrophage colony-stimulating factors. Science 229, 16-21.
33. Nabel, G., Baltimore, D., 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326, 711-713.
34. Nemunaitis, J., Singer, J.W., Buckner, C.D., 1988. Use of recombinant human granulocyte macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies. Blood 72, 834-836.
35. Novak, R.M., Holzer, T.J., Kennedy, M.M., Heynen, C.A., Dawson, G., 1990. The effect of interleukin 4 (BSF-1) on infection of peripheral blood monocyte-derived macrophages with HIV-1. AIDS Res. Hum. Retroviruses 8, 973-976.
36. Parhar, R.S., Ernst, P., Sheth, K.V., al-Sedairy, S.T., 1992. Anti-tumor cytotoxic potential and effect on human bone marrow GM-CFU of human LAK cells generated in response to various cytokines. Eur. Cytokine Netw. 3, 299-306.
37. Perno, C.F., Yarchoan, R., Cooney, D.A., Hartman, N.R., Webb, D.S., Hao, Z., Mitsuya, H., Dohns, D.G., Broder, S., 1989. Replication of human immunodeficiency virus in monocytes. Granulocyte/macrophage colony-stimulating factor (GM-CSF) potentiates viral production yet enhances the antiviral effect mediated by 3′-azido-2′3′-dideoxythymidine. J. Exp. Med. 169, 933-951.
38. Perno, C.F., Cooney, D.A., Gao, W.Y., Hao, Z., Johns, D.G., Foli, A., Hartman, N.R., Calio, R., Broder, S., Yarchoan, R., 1992. Effects of bone marrow stimulatory cytokines on human immunodeficiency virus replication and the antiviral activity of dideoxynucleosides in cultures of monocyte/macrophages. Blood 80, 995-1003.
39. Petit, A.J., Terpstra, F.G., Meidema, J., 1987. Human immunodeficiency virus infection down-regulates HLA class II expression and induces differentiation in promonocytic U937 cells. J. Clin. Invest. 79, 1883.
40. Poli, G., Fauci, A.S., 1992. The effect of cytokines and pharmacological agents on chronic HIV infection. AIDS Res. Hum. Retroviruses 9, 191-197.
41. Pomerantz, R.J., Feinberg, M.B., Trono, D., Baltimore, D., 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp. Med. 172, 253-261.
42. Rich, E.A., Chen, I.S.Y., Zack, J.A., Leonard, M.L., O'Brien, W.A., 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1 (HIV-1). J. Clin. Invest. 89, 176-183.
43. Roitt, I.M., Brostoff, J., Male, D.K., 1993. Immunology, 3rd edn. Mosby, UK.
44. Salahuddin, S.Z., Rose, R.M., Groopman, J.E., Markham, P.D., Gallo, R.C., 1986. Human T lymphotropic virus type III infection of human alveolar macrophages. Blood 68, 281-284.
45. Schuitemaker, H., Kootstra, N.A., van Oers, M.H.J., van Lambalgen, R., Tersmette, M., Miedema, F., 1990. Induction of monocyte proliferation and HIV expression by IL-3 does not interfere with anti-viral activity of zidovudine. Blood 76, 1490-1493.
46. Smith, P.D., Lamerson, C.L., Banks, S.M., Saini, S.S., Wahl, L.M., Calderone, R.A., Wahl, S.M., 1990. Granulocyte-macrophage colony stimulating factor augments human monocyte fungicidal activity for Candida albicans. J. Infect. Dis. 161, 999-1005.
47. Sonza, S., Maerz, A., Uren, S., Violo, A., Hunter, S., Boyle, W., Crowe, S., 1995. Susceptibility of human monocytes to HIV type-1 infection in vitro is not dependent on their level of CD4 expression. AIDS Res. Hum. Retroviruses 11, 769-776.
48. Sonza, S., Maerz, A., Deacon, N., Meanger, J., Mills, J., Crowe, S., 1996. Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol. 70, 3863-3869.
49. Vadas, M.A., Nicola, N.A., Metcalf, D., 1983. Activation of antibody-dependent cell-mediated cytotoxicity of human neutrophils and eosinophils by separate colony-stimulating factors. J. Immunol. 130, 795-799.
50. Walsh, D.G., Horvath, C.J., Hansen-Moosa, A., MacKey, J.J., Sehgal, P.K., Daniel, M.D., Desrosiers, R.C., Ringler, D.J., 1991. Cytokine influence on simian immunodeficiency virus replication within primary macrophages. Am. J. Pathol. 139, 877-887.
51. Yarchoan, R., Pluda, J.M., Perno, C.F., Mitsuya, H., Thomas, R.V., Wyvill, K.M., Broder, S., 1990. Initial clinical experience with dideoxynucleosides as single agents and in combination therapy. Ann. New York Acad. Sci. 616, 328-343.
52. Zack, J.A., Arrigo, S.J., Chen, I.S.Y., 1990. Control of expression and cell tropism of human immunodeficiency virus type 1. Adv. Virus Res. 38, 125-146.